Low BASDAI score alone is not a good predictor of anti-tumor necrosis factor treatment efficacy in ankylosing spondylitis: a retrospective cohort study

The purpose of this study was to determine the prevalence of high disease activity as measured using the Ankylosing Spondylitis Disease Activity Score (ASDAS) in ankylosing spondylitis (AS) patients who noneth...

Source: BMC Musculoskeletal Disorders - February 4, 2021 Category: Orthopaedics Authors: Bora Nam, Bon San Koo, Tae-Han Lee, Ji-Hui Shin, Jin-Ju Kim, Seunghun Lee, Kyung Bin Joo and Tae-Hwan Kim Tags: Research article Source Type: research